Cadence Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,438	Closed	-$553K	–	639
2016 Q2	$553K	Buy	+7,438	New	+$553K	0.04%	429
2015 Q4	–	Sell	-17,841	Closed	-$953K	–	631
2015 Q3	$953K	Sell	17,841 -39,830	-69%	-$2.13M	0.07%	303
2015 Q2	$3.63M	Buy	+57,671	New	+$3.63M	0.2%	133